Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5440.1070.9 (+1.32 %)
PREV CLOSE () 5369.20
OPEN PRICE () 5399.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1323
TODAY'S LOW / HIGH ()5355.00 5449.80
52 WK LOW / HIGH ()4716.75 5933
NSE5440.0069.5 (+1.29 %)
PREV CLOSE() 5370.50
OPEN PRICE () 5390.00
BID PRICE (QTY) 5440.00 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 80490
TODAY'S LOW / HIGH() 5353.50 5451.50
52 WK LOW / HIGH ()4716.2 5933.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Website : www.alkemlabs.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
07Apr Alkem Laboratories launches everyday m
Alkem Laboratories has launched A to Z Daily, an everyday multivitamin s..
31Mar Alkem Laboratories incorporates subsid
Alkem Laboratories has incorporated a wholly owned subsidiary (WOS) as a..
23Mar Alkem Laboratories launches semaglutid
Alkem Laboratories has launched semaglutide injection in India under the..
21Mar Alkem Laboratories informs about updat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
21Mar Alkem Laboratories informs about press
Alkem Laboratories has informed that it enclosed Press release on Alkem..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit6221.422808.9
Gross Profit 7061.5 23035.4
Operating Profit 8207.426632.6
Net Sales 24912.788134.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8291.50 (2.93%)
M.Cap ( in Cr)
20728.75
Neuland Laboratories (BSE)
 14948.95 (1.46%)
M.Cap ( in Cr)
19179.34
Divi's Lab (BSE)
 6119.50 (2.72%)
M.Cap ( in Cr)
162453.50
Procter&Gamble Healt (BSE)
 4943.65 (2.88%)
M.Cap ( in Cr)
8206.15
Pfizer (BSE)
 4865.30 (2.46%)
M.Cap ( in Cr)
22257.64
Shareholding Pattern
PROMOTERS 51.2%
NON-INSTITUTION 17.3%
MUTUAL FUNDS/UTI 16.06%
FI/BANKS/INSURANCE 3.96%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77550.25918.60 (1.20%)
NIFTY24050.60275.50 (1.16%)
Dow Jones 47916.57-269.23 (-0.56%)
Nasdaq 22902.8980.47 (0.35%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI